YOLFTbeta
Solbar Ningbo Protein Technology Co., Ltd.

Solbar Ningbo Protein Technology Co., Ltd.

603231 · SHG · Consumer Defensive / Packaged Foods

16.78CNY-0.11 (-0.65%)

Price History

Full chart

Market Stats

Previous Close16.89
Open16.89
Day Range16.71 – 17.00
52-Week Range13.70 – 21.85
Volume857.53K
Market Cap3.30B
P/E (TTM)20.55
Forward P/E0.00
EPS0.84
Dividend Yield3.88%
Beta0.56
50-Day Avg16.04
200-Day Avg17.15

About

Solbar Ningbo Protein Technology Co., Ltd. engages in the research and development, production, and sale of soybean protein products in China and internationally. It offers functional and textured soy protein concentrates, textured soy proteins, textured fibrous vegetable proteins, isolated soy proteins, defatted soy flours, soy flake, soy flour, soy lecithin, soy isoflavone, and non-GMO soybean oil, which are widely used in food, soy dietary fiber, health products, plant-based food, pharmaceutical fermentation, pet food and other fields. The company provides products through its network of distributors, as well as through direct sales to multinational customers. Solbar Ningbo Protein Technology Co., Ltd. was founded in 2003 and is based in Ningbo, China.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Yongheng Dai
  • Employees947
  • HeadquartersNo. 12 Xingye Avenue, Ningbo, China, 315800, China
  • Websitehttps://www.solbar.com

Leadership

  • Mr. Yongheng DaiGM & Director · b. 1974
  • Mr. Jiguo FangCFO, Board Secretary & Director · b. 1975
  • Mr. Jun YuanDeputy General Manager · b. 1973
  • Mr. Hongfei WangDeputy General Manager · b. 1978

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.06B1.28B1.59B1.85B1.75B1.56B1.75B
Growth (%)-+20.25%+24.05%+16.44%-5.33%-11.04%+12.39%
Cost of Revenue891.98M1.09B1.36B1.60B1.51B1.37B1.46B
Gross Profit171.33M184.11M222.02M243.89M236.62M182.70M291.63M
Gross Margin16.11%14.40%14.00%13.21%13.53%11.75%16.68%
Operating Expense89.78M64.28M75.46M54.60M57.04M34.40M72.80M
Operating Income81.56M119.83M146.56M189.28M179.58M148.30M218.84M
Operating Margin7.67%9.37%9.24%10.25%10.27%9.53%12.52%
EBITDA131.02M165.58M189.55M246.44M237.98M211.48M302.17M
EBITDA Margin12.32%12.95%11.95%13.34%13.61%13.60%17.29%
Net Income65.99M97.75M123.94M168.03M145.98M121.18M189.72M
Net Income Margin6.21%7.64%7.81%9.10%8.35%7.79%10.85%
R&D7.89M11.15M12.39M12.24M10.45M10.41M8.12M
R&D as % of Total Revenue0.74%0.87%0.78%0.66%0.60%0.67%0.46%
Interest Expense7.00M2.78M2.92M6.08M2.92M577.59K80.95K
Interest Expense % of Total Revenue0.66%0.22%0.18%0.33%0.17%0.04%0.00%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets758.83M753.27M974.36M1.14B2.14B2.08B2.27B
Total Liabilities202.54M118.94M286.31M342.29M242.56M210.23M262.51M
Total Equity556.29M634.34M688.05M802.62M1.93B1.87B2.01B
Cash23.06M70.27M122.98M88.05M1.07B320.03M238.75M
Total Debt45.78M22.17M106.19M85.77M84.05M23.77M-
Net Debt22.73M-48.09M-16.79M-2.28M-989.09M-296.25M-

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow44.43M199.31M161.95M186.39M143.91M147.69M311.11M
Investing Cash Flow-126.05M-43.04M-111.88M-143.69M-95.84M-655.96M-
Financing Cash Flow57.65M-110.14M8.05M-82.02M936.67M-249.47M-
Capital Expenditure38.42M72.53M160.53M144.11M99.67M168.51M189.99M
Free Cash Flow6.01M126.78M1.42M42.27M44.24M-20.83M121.12M
Dividends Paid36.75M29.78M74.09M63.09M43.08M95.90M57.49M
FCF to OCF13.53%63.61%0.88%22.68%30.74%-14.10%38.93%
Dividend Paid to FCF611.12%23.49%5216.86%149.23%97.38%-460.51%47.47%

Key Statistics & Ratios

Market Cap3.30B
Enterprise Value2.52B
Trailing P/E20.55
Forward P/E0.00
Price / Sales1.70
Price / Book1.64
EPS0.84
Book Value10.47
Revenue (TTM)1.94B
Gross Profit (TTM)269.62M
EBITDA271.40M
Profit Margin8.27%
Operating Margin8.85%
Return on Equity8.13%
Return on Assets5.30%
Shares Outstanding191.46M
Shares Float74.28M
Beta0.56
Dividend Yield3.88%
Dividend Rate0.67
Payout Ratio44.05%

Dividends

20262×
0.30Jun 26, 20260.07Feb 12, 2026
20251×
0.30Jun 30, 2025
20241×
0.50Jun 28, 2024